Registered number
15013039
AVI MEDICS LTD
Filleted Accounts
31 July 2025
AVI MEDICS LTD
Registered number: 15013039
Balance Sheet
as at 31 July 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 1,240 1,240
Current assets
Cash at bank and in hand 10 880
Creditors: amounts falling due within one year 4 (2,888) (753)
Net current (liabilities)/assets (2,878) 127
Net (liabilities)/assets (1,638) 1,367
Capital and reserves
Called up share capital 100 100
Profit and loss account (1,738) 1,267
Shareholders' funds (1,638) 1,367
Number Number
Average number of employees 1 1
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Anne Manjalee Liyanage
Director
Approved by the board on 29 April 2026
AVI MEDICS LTD 15013039 false 2024-08-01 2025-07-31 2025-07-31 VT Final Accounts April 2025 Dr Anne Manjalee Liyanage No description of principal activity 15013039 core:WithinOneYear 2024-07-31 15013039 core:ShareCapital 2024-07-31 15013039 core:RetainedEarningsAccumulatedLosses 2024-07-31 15013039 2024-08-01 2025-07-31 15013039 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15013039 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15013039 bus:Director40 2024-08-01 2025-07-31 15013039 bus:FRS102 2024-08-01 2025-07-31 15013039 bus:FilletedAccounts 2024-08-01 2025-07-31 15013039 2025-07-31 15013039 core:WithinOneYear 2025-07-31 15013039 core:ShareCapital 2025-07-31 15013039 core:RetainedEarningsAccumulatedLosses 2025-07-31 15013039 2024-07-31 iso4217:GBP xbrli:pure